Esra Bağlan
Impact in
-
- Gout, Hyperuricemia, Uric Acid
-
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Inflammasome and immune disorders 19
- Immunology 12
- IL-33, ST2, and ILC Pathways 6
- Co-authors
- Semanur Özdel (31 shared papers)Mehmet Bülbül (28 shared papers)Nuray Aktay Ayaz (15 shared papers)Betül Sözeri (15 shared papers)Hafize Emine Sönmez (14 shared papers)Mustafa Çakan (15 shared papers)Kübra Öztürk (14 shared papers)Gülçin Otar Yener (14 shared papers)
- Journals
- Modern Rheumatology (4 papers)Clinical Rheumatology (4 papers)Pediatric Nephrology (2 papers)Lupus (2 papers)Frontiers in Pediatrics (2 papers)
- Partner nations
- TürkiyeUnited StatesAntigua and Barbuda
In The Last Decade
Esra Bağlan
36 papers receiving 177 citations
Peers
Comparison fields: 5 of 42
- Nephrology 32
- Hematology 44
- Rheumatology 47
- Immunology 60
- Ophthalmology 15
Countries citing papers authored by Esra Bağlan
This map shows the geographic impact of Esra Bağlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Bağlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Bağlan more than expected).
Fields of papers citing papers by Esra Bağlan
This network shows the impact of papers produced by Esra Bağlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Bağlan. The network helps show where Esra Bağlan may publish in the future.
Co-authors
The 25 scholars most cited alongside Esra Bağlan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 35 | |
| 2 | 2019 | 14 | |
| 3 | 2021 | 13 | |
| 4 | 2022 | 13 | |
| 5 | 2022 | 10 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 7 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 6 | |
| 10 | 2022 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2021 | 5 | |
| 13 | 2019 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2020 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2021 | 3 |
About Esra Bağlan
Esra Bağlan is a scholar working on Molecular Biology, Immunology, Surgery, Rheumatology and Hematology, having authored 43 papers that have together received 181 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (19 papers), Autoimmune and Inflammatory Disorders Research (11 papers), Kawasaki Disease and Coronary Complications (9 papers), IL-33, ST2, and ILC Pathways (6 papers), Systemic Lupus Erythematosus Research (6 papers), Vasculitis and related conditions (4 papers), Ocular Diseases and Behçet’s Syndrome (4 papers) and Gout, Hyperuricemia, Uric Acid (3 papers). The work is most often cited by research in Nephrology (32 citations), Hematology (44 citations), Rheumatology (47 citations), Immunology (60 citations) and Ophthalmology (15 citations). Esra Bağlan has collaborated with scholars based in Türkiye, United States and Antigua and Barbuda. Frequent co-authors include Semanur Özdel, Mehmet Bülbül, Nuray Aktay Ayaz, Betül Sözeri, Hafize Emine Sönmez, Mustafa Çakan, Kübra Öztürk, Gülçin Otar Yener, Ferhat Demir and Şerife Gül Karadağ. Their work appears in journals such as Modern Rheumatology, Clinical Rheumatology, Pediatric Nephrology, Lupus and Frontiers in Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.